BCM
THRX

BML Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

BML Capital Management’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,108,320
Closed -$4.49M – 37
2023
Q4 		$4.49M Buy
+1,108,320
New +$3.38M 3.4% 8

BML Capital Management's THRX Position: Q1 2024 in Review

BML Capital Management sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 1,108,320 shares — an estimated $4.49M sold.

BML Capital Management first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $4.49M in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

  • BML Capital Management reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • BML Capital Management sold 1,108,320 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $4.49M.
  • BML Capital Management first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • BML Capital Management's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $4.49M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on BML Capital Management's 13F filing for Q1 2024, filed 23 Apr 2024.